Skip to content

Author

P. Nazarey

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Characteristics associated with response to teduglutide in pediatric short bowel syndrome-associated intestinal failure: Post hoc analysis of open-label long-term extension trials

Background Teduglutide can reduce dependence on parenteral nutrition and/or intravenous fluids (PN/IV) in children with short bowel syndrome-associated intestinal failure (SBS-IF). Material and methods A post-hoc analysis was conducted using data from open-label long-term extension (LTE) trials (NCT02949362, NCT0295445...

S. Hill, Beth Carter, Valeria C. Cohran et al. · 0 citations
Review Open access Sep 2026

Effectiveness, safety, and quality of life outcomes of teduglutide treatment in adult patients with short bowel syndrome-associated intestinal failure: A systematic literature review of real-world studies

10 years of real-world evidence on the effectiveness, including HRQoL, and safety of teduglutide in treating adults with SBS-IF in clinical practice is summarized, across phenotypic anatomic groups including patients with stomas and patients with colon in continuity.

Shirley C. Paski, A. Becher, P. Nazarey et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.